← Leaderboards
Arindam Bhattacharjee
Parabase Genomics
$2,176,554
Attributed
$2,416,564
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $778.7K · FY2013–20$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$2,416,564 · 5
By mechanism
R44$1,721,521 · 2
R43$695,043 · 3
Top collaborators
- Edwin W Naylor2 shared
Others in their field
Top investigators on “Next Generation Sequencing”
- Richard K. Wilson · Washington University$212,061,459
- Richard A Gibbs · Baylor College Of Medicine$154,545,986
- Gaetano T Montelione · Rutgers The St Univ Of Nj New Brunswick$123,768,030
- David Heimbrook · Leidos Biomedical Research, Inc.$88,754,196
- Stacey Gabriel · Massachusetts Institute Of Technology$56,000,154
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$49,363,804
Research focus
Next Generation SequencingScreeningGenesNewborn InfantPublic HealthSamplingEnzyme ActivityEnzymesMeasurementNeonatal ScreeningPathogenicityDatabasesReportingBloodBiochemicalCreatine KinaseAffectClinical DiagnosisCostInterestCopy Number PolymorphismMuscleAlgorithmsServices
Grant awards (6)
Feasibility and validation of an integrated newborn screening algorithm with targeted Next Generation Sequencing (tNGS) technology as part of a 2nd-tier test for Pompe and MPS I$778,727
R44 · FY2020 · HD · contact PI
A Comprehensive Newborn Screening Solution for Duchenne and Congenital Muscular Dystrophies$710,423
R44 · FY2019 · HD · contact PI
A Comprehensive Newborn Screening Solution for Duchenne and Congenital Muscular Dystrophies$232,371
R44 · FY2018 · HD · contact PI
Feasibility and validation of an integrated newborn screening algorithm with the targeted Next Generation Sequencing (tNGS) technology as part of a 2nd tier test for Pompe and MPS I$215,022
R43 · FY2018 · HD · contact PI
Development and Validation of a High Risk and Potential Newborn Screening for Inh$279,494
R43 · FY2013 · HD · contact PI
Confirmatory Screening for Congenital Non-Syndromic Genetic Hearing Loss Using Ta$200,527
R43 · FY2013 · DC · contact PI